Utilizing Shared Decision-Making to Optimize Therapy for Anemia in CKD


Bruce Spinowitz
Associate Director, Nephrology
Vice Chairman, Medicine
New York Presbyterian Queens
Professor of Clinical Medicine
Weill Cornell Medical College
New York, NY
Bruce Spinowitz

Bruce Spinowitz, MD, is a practicing nephrologist in Queens, New York. He is vice chairman of the Department of Medicine and associate director of the Renal Division at New York-Presbyterian Queens in Flushing as well as a professor of clinical medicine at Weill Medical College of Cornell University in New York City. Dr. Spinowitz graduated from New York University School of Medicine in 1973. He completed an internship and residency in internal medicine at Bellevue Hospital in New York City. Dr. Spinowitz was a National Institutes of Health (NIH) postdoctoral fellow in physiology and completed a second fellowship in nephrology at New York University School of Medicine. He is board-certified in internal medicine and nephrology.

Dr. Spinowitz’s research areas of interest include diabetic nephropathy, anemia, lupus nephritis, secondary hypoparathyroidism, peritoneal dialysis, and new therapies for hyperkalemia. He is a member of the National Kidney Foundation Medical Advisory Board. Dr. Spinowitz has published more than 60 original research articles in peer-reviewed journals. He has more than 80 abstracts and posters presented nationally and internationally at the annual meetings of the International Society of Nephrology (ISN), the American Society for Artificial Internal Organs (ASAIO), the American Society of Nephrology (ASN), the International Society of Peritoneal Dialysis (ISPD), the American Diabetes Association, and the American College of Clinical Pharmacy (ACCP).

Dr. Spinowitz is a fellow of the American College of Physicians and a member of the ASN, ISN, ISPD, and Renal Physicians Association. Since 2001, he has been a Castle Connolly “Top Doctor” and was awarded Nephrologist of the Year by the American Kidney Foundation in 2014.

Statement of Need

Shared decision-making (SDM) is a collaborative effort between patients and clinicians to share evidence and consider options regarding health care decisions. SDM is a significant facet of chronic kidney disease (CKD) care and is especially relevant for anemia in CKD, wherein treatment options carry uncertainty and variability. Patients, however, lack knowledge of anemia in CKD; many patients are not aware of their hemoglobin levels or recognize that their anemia and kidney disease are linked, and only half understand different treatment options. It is imperative that clinicians are appraised of how to educate CKD patients with anemia and facilitate informed care decisions, especially in the sensitive contexts of life experience and culture for underserved and rural populations.
In the third activity of this CME Outfitters BriefCase series, expert faculty utilize case-based learning to guide learners on integration of SDM principles to ensure that patient needs and preferences are aligned with anemia and CKD treatment plans.

Learning Objectives

At the conclusion of this activity, learners will be able to better:

  • Integrate SDM principles to ensure that patient needs and preferences are aligned with anemia and CKD treatment plans

Financial Support

This educational activity is supported by an educational grant from GSK.

Target Audience

Physicians, physician associates (PAs), nurse practitioners (NPs), nurses, and pharmacists specializing in nephrology or primary care

Credit Information

Jointly Accredited Provider

In support of improving patient care, CME Outfitters, LLC, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional (IPCE) 0.5

This activity was planned by and for the healthcare team, and learners will receive 0.50 Interprofessional Continuing Education Credit for learning and change.

Physicians (ACCME) 0.5

CME Outfitters, LLC, designates this Enduring Material for a maximum of 0.50 AMA PRA Category 1 Credit(s)™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Nurses (ANCC) 0.5

This activity is designated for 0.50 contact hours.

California Residents: This continuing nursing education activity was approved by the California Board of Registered Nursing. CME Outfitters LLC’s provider number is CEP15510.

Pharmacists (ACPE) 0.5

This application-based activity is approved for 0.50 contact hours ( 0.05 CEUs) of continuing pharmacy credit ( JA0007185-0000-23-140-H01-P ).

PAs (AAPA) 0.5

CME Outfitters, LLC, has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1 CME credit for activities planned in accordance with AAPA CME Criteria. This activity is designated for 0.50 AAPA Category 1 CME credits. Approval is valid until 12/20/2024. PAs should only claim credit commensurate with the extent of their participation.


Successful completion of this CME activity, which includes participation in the evaluation component, enables the participant to earn up to 0.50 medical knowledge MOC points in the American Board of Internal Medicine’s (ABIM) Maintenance of Certification (MOC) program. Participants will earn MOC points equivalent to the amount of CME credits claimed for the activity. It is the CME activity provider’s responsibility to submit participant completion information to ACCME for the purpose of granting ABIM MOC credit.

MIPS Improvement Activity

Completion of this accredited CME activity meets the expectations of an Accredited Safety or Quality Improvement Program (IA_PSPA_28) for the Merit-based Incentive Payment Program (MIPS). Clinicians should submit their improvement activities by attestation via the CMS Quality Payment Program website.

Royal College MOC

Through an agreement between the Accreditation Council for Continuing Medical Education and the Royal College of Physicians and Surgeons of Canada, medical practitioners participating in the Royal College MOC Program may record completion of accredited activities registered under the ACCME’s “CME in Support of MOC” program in Section 3 of the Royal College’s MOC Program.

Disclosure Declaration

Dr. Spinowitz reports the following financial relationships:

Advisory Board: Akebia Therapeutics, Inc.; AstraZeneca; GSK; and Renibus Therapeutics
Research Support: AstraZeneca and Travere Therapeutics, Inc.
Speakers Bureau: AstraZeneca; GSK; and Fresenius

The following individuals have no financial relationships to disclose: 

Jeffrey Helfand, DO (Peer Reviewer)
Albert Eubanks, Jr., RN (Peer Reviewer)
Keshia Pitt, PhD (Planning Committee)
John Jones, PharmD (Planning Committee)
Susan H. Yarbrough, CHCP (Planning Committee)
Sandra Caballero, PharmD (Planning Committee)
Sharon Tordoff (Planning Committee)

Obtaining Credit

Post-tests, credit request forms, and activity evaluations must be completed online (requires free account activation), and participants can print their certificate or statement of credit immediately (0% pass rate required). This website supports all browsers except Internet Explorer for Mac.

Questions about this activity?

Call us at 877.CME.PROS (877.263.7767).


Utilizing Shared Decision-Making to Optimize Therapy for Anemia in CKD
Event Date: 12/20/2023 at 5:00 am EST